Filtered By:
Condition: Abdominal Aortic Aneurysm

This page shows you your search results in order of date. This is page number 15.

Order by Relevance | Date

Total 234 results found since Jan 2013.

Upper extremity access for fenestrated endovascular aortic aneurysm repair is not associated with increased morbidity
Fenestrated endovascular aortic aneurysm repair (FEVAR) is an alternative to open repair in patients with complex abdominal aortic aneurysms who are neither fit nor suitable for standard open or endovascular repair. Chimney and snorkel grafts are other endovascular alternatives but frequently require bilateral upper extremity access that has been associated with a 3% to 10% risk of stroke. However, upper extremity access is also frequently required for FEVAR because of the caudal orientation of the visceral vessels.
Source: Journal of Vascular Surgery - August 2, 2014 Category: Surgery Authors: Martyn Knowles, David A. Nation, David E. Timaran, Luis F. Gomez, M. Shadman Baig, R. James Valentine, Carlos H. Timaran Tags: Clinical Paper Source Type: research

Endovascular treatment for ruptured abdominal aortic aneurysm.
CONCLUSIONS: The conclusions of this review are currently limited by the paucity of data. From the data available there is no difference in the outcomes evaluated in this review between eEVAR and open repair, specifically 30-day mortality. Not enough information was provided for complications in order to make a well informed conclusion at this time. Long-term data are lacking for both survival and late complications. More high quality, randomised controlled trials comparing eEVAR and open repair for the treatment of RAAA are needed in order to better understand if one method is superior to the other, or if there is no diff...
Source: Cochrane Database of Systematic Reviews - July 21, 2014 Category: Journals (General) Authors: Badger S, Bedenis R, Blair PH, Ellis P, Kee F, Harkin DW Tags: Cochrane Database Syst Rev Source Type: research

Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease.
CONCLUSIONS:: These data suggest that many people with high CHD risk, especially those with an FRS >20%, do not receive guideline-concordant lipid-lowering therapy and do not achieve an LDL-C <100 mg/dL. PMID: 24892511 [PubMed - as supplied by publisher]
Source: The American Journal of the Medical Sciences - June 2, 2014 Category: Journals (General) Authors: Gamboa CM, Safford MM, Levitan EB, Mann DM, Yun H, Glasser SP, Woolley JM, Rosenson R, Farkouh M, Muntner P Tags: Am J Med Sci Source Type: research

Systolic, diastolic blood pressures predict risk of different cardiovascular diseases
Raised systolic and diastolic blood pressures may have different effects on different types of cardiovascular diseases and at different ages, according to new research involving 1.25 million patients from primary care practices. The new findings suggest that individuals with higher systolic blood pressures have a greater risk of intracerebral haemorrhage (stroke caused by bleeding within the brain tissue), subarachnoid haemorrhage (the deadliest form of stroke), and stable angina, whereas raised diastolic blood pressure is a better indicator of abdominal aortic aneurysm risk.
Source: ScienceDaily Headlines - May 30, 2014 Category: Science Source Type: news

Parallel Endografts in the Treatment of Distal Aortic and Common Iliac Aneurysms
Conclusions: Successful exclusion of D-AAA and BCIAA was achieved in high-risk patients using parallel endografts, allowing antegrade blood flow to one IIA when needed. Commercially available endografts were used in a simple and effective approach, with excellent follow-up results.
Source: European Journal of Vascular and Endovascular Surgery - May 19, 2014 Category: Surgery Authors: S. Lepidi, M. Piazza, P. Scrivere, M. Menegolo, M. Antonello, F. Grego, P. Frigatti Tags: Aortic Disease Source Type: research

Parallel Endografts in the Treatment of Distal Aortic and Common Iliac Aneurysms.
CONCLUSIONS: Successful exclusion of D-AAA and BCIAA was achieved in high-risk patients using parallel endografts, allowing antegrade blood flow to one IIA when needed. Commercially available endografts were used in a simple and effective approach, with excellent follow-up results. PMID: 24846490 [PubMed - as supplied by publisher]
Source: PubMed: Eur J Vasc Endovasc ... - May 17, 2014 Category: Surgery Authors: Lepidi S, Piazza M, Scrivere P, Menegolo M, Antonello M, Grego F, Frigatti P Tags: Eur J Vasc Endovasc Surg Source Type: research

Reasons for non‐participation in population‐based abdominal aortic aneurysm screening
ConclusionEfforts to improve participation in AAA screening should target the groups with low income, a low level of education and immigrants. The higher morbidity in the non‐participant group, together with a higher rate of smoking, make it probable that this group also has a high risk of AAA.
Source: British Journal of Surgery - February 26, 2014 Category: Surgery Authors: A. Linne, K. Leander, D. Lindström, S. Törnberg, R. Hultgren Tags: Original Article Source Type: research

Tumor Necrosis Factor α Inhibitor Use and Decreased Risk for Incident Coronary Events in Rheumatoid Arthritis
ConclusionUse of TNFα inhibitors is associated with a decreased risk for CAD in RA; the risk decreases further with long‐term use. This should be considered when weighing the risks versus benefits of these medications.
Source: Arthritis Care and Research - February 24, 2014 Category: Rheumatology Authors: Androniki Bili, Xiaoqin Tang, Shruthi Pranesh, Rasa Bozaite, Stephanie J. Morris, Jana L. Antohe, H. Lester Kirchner, Mary Chester M. Wasko Tags: Rheumatoid Arthritis Source Type: research

This Week in Cardiology: Advances in Stroke, Heart Medicine
(MedPage Today) -- Two installments of Hot Topics will feature predictions about the big developments expected in stroke and cardiovascular medicine. And guidelines will be in the headlines again, this time for abdominal aortic aneurysm.
Source: MedPage Today Cardiovascular - January 27, 2014 Category: Cardiology Source Type: news

Patients with Acute Thoracic Aortic Dissection: A One-Year Case Series of Patients Presenting to an ED
Thoracic dissection is an often fatal disease. Although physicians must have a high level of suspicion for this disorder, up to 38% of patients with dissection do not have it suspected on evaluation, and up to 28% are found on autopsy not to have been correctly diagnosed. Although rare, thoracic aortic dissection is the most common lethal disease affecting the aorta and more common than abdominal aortic aneurysm (AAA) rupture. Mortality can be as high as 1–2% per hour, making quick and accurate diagnosis important. This is made more complex by the various presentations of thoracic dissection, based on area of dissection,...
Source: The Journal of Emergency Medicine - January 23, 2014 Category: Emergency Medicine Authors: D. Salo, F. Fiesseler, K. Baldino, H. Patel Source Type: research

Endovascular repair of abdominal aortic aneurysm.
CONCLUSIONS: In individuals considered fit for conventional surgery, EVAR was associated with lower short-term mortality than OSR. However, this benefit from EVAR did not persist at the intermediate- and long-term follow ups. Individuals undergoing EVAR had a higher reintervention rate than those undergoing OSR. Most of the reinterventions undertaken following EVAR, however, were catheter-based interventions associated with low mortality. Operative complications, health-related quality of life and sexual dysfunction were generally comparable between EVAR and OSR. However, there was a slightly higher incidence of pulmonary ...
Source: Cochrane Database of Systematic Reviews - January 23, 2014 Category: Journals (General) Authors: Paravastu SC, Jayarajasingam R, Cottam R, Palfreyman SJ, Michaels JA, Thomas SM Tags: Cochrane Database Syst Rev Source Type: research

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF
Conclusion Patients with PAD in ROCKET AF did not have a statistically significant higher risk of stroke or systemic embolism than patients without PAD, and there were similar efficacy outcomes in patients treated with rivaroxaban and warfarin. In PAD patients, there was a higher risk of major bleeding or NMCR bleeding with rivaroxaban when compared with warfarin (interaction P = 0.037). Further investigation is warranted to validate this subgroup analysis and determine the optimal treatment in this high-risk cohort of AF patients with PAD.
Source: European Heart Journal - January 21, 2014 Category: Cardiology Authors: Jones, W. S., Hellkamp, A. S., Halperin, J., Piccini, J. P., Breithardt, G., Singer, D. E., Fox, K. A. A., Hankey, G. J., Mahaffey, K. W., Califf, R. M., Patel, M. R. Tags: Atrial fibrillation Source Type: research

Gender difference in long-term prognosis among patients with cardiovascular disease
Conclusion: Women with cardiovascular disease who received a similar standardized cardiovascular work-up and personalized therapy advice as men had a favourable long-term outcome.
Source: European Journal of Preventive Cardiology - December 16, 2013 Category: Cardiology Authors: van der Meer, M. G., Cramer, M. J., van der Graaf, Y., Doevendans, P. A., Nathoe, H. M., (on behalf of the SMART study group) Tags: Original scientific papers Source Type: research

Metabolic Syndrome and Non-Cardiac Vascular Diseases: an Update from Human Studies.
Abstract The metabolic syndrome (MetS) is characterized by a cluster of risk factors including central obesity, hypertension, dyslipidemia and insulin resistance, The MetS is associated with an increased risk for cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Several international organizations have defined MetS using different diagnostic criteria that produced discrepancies in the results of previous studies, thus leading to the latest Joint Interim Societies (JIS) MetS definition. Other risk factors than the diagnostic criteria that have been associated with MetS include lipid abnormalities, u...
Source: Current Pharmaceutical Design - December 5, 2013 Category: Drugs & Pharmacology Authors: Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP Tags: Curr Pharm Des Source Type: research